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Abstract A novel antimicrobial peptide, named misgurin, was
isolated and characterized from the loach (mudfish), Misgurnus
anguillicaudatus. The 21-amino-acid peptide with a molecular
mass of 2502 Da was purified to homogeneity using a heparin-
affinity column and C18 reverse-phase and gel-permeation high-
performance liquid chromatography. The complete amino acid
sequence of misgurin, which was determined by an automated
amino acid sequencer, was Arg^Gln^Arg^Val^Glu^Glu^Leu^
Ser^Lys^Phe^Ser^Lys^Lys^Gly^Ala^Ala^Ala^Arg^Arg^Arg^
Lys. Misgurin is a strongly basic peptide which has 5 arginine
and 4 lysine residues. Comparison of the amino acid sequence
with those of other known antimicrobial peptides revealed that
misgurin was a novel antimicrobial peptide. Misgurin showed a
strong antimicrobial activity in vitro against a broad spectrum of
microorganisms without significant hemolytic activity and was
about 6 times more potent than magainin 2. Scanning electron
microscopy confirmed that the peptide caused damage to the cell
membrane by a pore-forming mechanism similar to that of
magainin 2. This damage occurred at the minimal inhibition
concentration (MIC), but at higher concentration than MIC it
lysed the cell.
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1. Introduction
Bacteria and fungi coexist with all living organisms. How-
ever, considering the number and diversity of microorganisms
with which they are in constant contact, microbial invasion to
the hosts is rare, likely because of their unique defense sys-
tems. One such system is that of non-speci¢c immunity which
comprises a wide variety of peptides with potent antimicrobial
activities [1]. More than 2000 antimicrobial peptides, which
possess antimicrobial activities against bacteria, fungi and en-
veloped viruses with little or no cytolytic activity [2,3], have
been isolated from diverse biological sources, including am-
phibians [4], insects [5], mammals [6], plants [7] and prokar-
yotes [8]. Cecropins were the ¢rst well-characterized family of
structurally related antimicrobial peptides that were found in
a wide distribution of insects [5]. In amphibians, which are
rich in antimicrobial peptides, many amphipathic K-helical
antimicrobial peptides such as magainins [4], bombinins [9],
buforins [10] and dermaseptin [11], as well as carboxy-termi-
nal disul¢de bridged peptides like the esculentins and brevi-
nins [12], have been isolated from the glands of the skin and
gastrointestinal tract. Defensins were found in phagocytic cells
isolated from several mammalian species, including human [6].
Most of these antimicrobial peptides, although a few non-
high-cationic antimicrobial peptides have been recently char-
acterized [13], share the properties of being cationic but oth-
erwise di¡er considerably in such basic features as their size,
the presence of disulphide bonds and structural motifs [14].
To date, the majority of structural and biological studies on
antimicrobial peptides have been limited to those from terres-
trial life. Few studies have been performed on antimicrobial
peptides from underwater organisms. Pardaxins, mytilins and
tachyplesins, which were found in Moses sole ¢sh [15], mus-
sels [16] and horseshoe crab [17], respectively, were the only
antimicrobial peptides so far isolated from marine organisms.
Pardaxins, however, showed strong hemolytic activity. So far,
natural ¢sh antimicrobial peptides without hemolytic activity
have not been reported. In this study, we report the puri¢ca-
tion and characterization of an antimicrobial peptide from the
loach (or mud¢sh), Misgurnus anguillicaudatus, which exhib-
ited potent antimicrobial activities against Gram-negative and
Gram-positive bacteria and fungi without signi¢cant hemo-
lytic activity.
2. Materials and methods
2.1. Peptide puri¢cation
An antimicrobial peptide was puri¢ed from the loach (Misgurnus
anguillicaudatus) as described previously by Park et al. [10]. Loaches
(200 g) were homogenized using a Waring blender (Waring, New
Hartford, CT) in 400 ml of acidic medium containing 1% (v/v) tri-
£uoroacetic acid (TFA), 1 M HCl, 5% (v/v) formic acid, 1% (w/v)
NaCl and pepstatin A at 1 Wg/ml. The homogenate was centrifuged at
20 000Ug for 30 min in a Himac SCR20BR (Hitachi, Tokyo, Japan)
and the supernatant was collected. The peptides in the supernatant
were then subjected to reverse-phase concentration using a Sep-Pak
C18 cartridge (Millipore, Milford, MA) which was activated with 80%
acetonitrile containing 0.1% (v/v) TFA and £ushed with 0.1% (v/v)
TFA to remove the excess acetonitrile. After being loaded with the
supernatant, the cartridge was washed with 20 ml of 0.1% (v/v) TFA
and the peptides trapped in the Sep-Pak C18 cartridge were eluted
with 6 ml of 80% (v/v) acetonitrile containing 0.1% (v/v) TFA. The
eluate was then lyophilized and subsequently resuspended in 10 ml of
0.01 M Tris-HCl (pH 7.5) containing 0.01 M NaCl. The resuspended
eluate was loaded onto a 1.0U10 cm Heparin Sepharose column
(Pharmacia, Uppsala, Sweden) equilibrated with 0.01 M Tris-HCl
(pH 7.5) containing 0.01 M NaCl [18]. The bound peptides were
eluted by 0.1 M, 0.5 M and 1 M NaCl, respectively, and concentrated
in 2 ml of 0.1% (v/v) TFA using Sep-Pak C18 cartridges. Five micro-
liters of each sample was then assayed for antimicrobial activity
against Bacillus subtilis. The active eluate was run on a C18 reverse-
phase high-performance liquid chromatography (HPLC) column
(3.9U300 mm, Delta Pak, Millipore). The peptides loaded into the
column were eluted with a linear gradient of 0^50% in 1 h at a £ow
rate of 1 ml/min with bu¡er A (0.1% TFA in H
2
O) and bu¡er B
(0.1% TFA in acetonitrile). Each fraction was dried under vacuum
and resuspended in water. Five microliters of the resuspended pep-
tides was assayed for antimicrobial activity as before. The active frac-
tion was further puri¢ed on an 8U300 mm Protein KW-802.5 gel-
permeation HPLC column (Millipore). The purity of the isolated pep-
tide was assessed by tricine SDS-PAGE and a matrix-associated laser
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desorption ionization (MALDI) mass spectroscopy (Kratos Kompact
MALDI, Manchester, UK).
2.2. Antimicrobial assays
The antimicrobial activity was examined during each puri¢cation
step by the radial di¡usion assay on B. subtilis lawn as described by
Lehrer et al. [19]. A 20 ml culture of B. subtilis cells in mid-logarith-
mic phase was washed with cold 10 mM sodium phosphate bu¡er
(NAPB), pH 7.4, and resuspended in 10 ml of cold NAPB. A volume
containing 1U10
6
bacterial CFU was added to 6 ml of underlayer
agar (10 mM sodium phosphate, 1% (v/v) trypticase soy broth, 1%
agarose, pH 6.5) and the mixture was poured into a Petri dish. Sam-
ples were added directly to the 3-mm wells made on the solidi¢ed
underlayer agar. After incubation for 3 h at 37³C, the underlayer
agar was covered with a nutrient-rich top agar overlay and incubated
overnight at 37³C. Antimicrobial activity was determined by observ-
ing the zone of suppression of bacterial growth around the 3-mm
wells. The minimal inhibitory concentrations (MIC) of the isolated
peptide against several Gram-positive and Gram-negative bacteria
and fungi were determined as described by Park et al. [10]. The lowest
concentration of antimicrobial peptide which showed visible suppres-
sion of growth was de¢ned as the MIC.
2.3. Hemolysis assay
Hemolytic activity was assayed as described by Aboudy et al. [20]
with a slight modi¢cation. Freshly packed sheep erythrocytes (3 ml)
[9] was washed with isotonic phosphate-bu¡ered saline (PBS), pH 7.4,
until the color of the supernatant turned clear. The washed erythro-
cytes were then diluted to a ¢nal volume of 20 ml with the same
bu¡er. To 190 Wl of the cell suspension in microfuge tubes, peptide
samples (10 Wl), serially diluted in PBS, were added. Following gentle
mixing, the tubes were incubated for 30 min at 37³C and then centri-
fuged at 4000 rpm for 5 min. One hundred microliters of supernatant
was taken, diluted to 1 ml with PBS, and OD
567
was determined. The
relative optical density, as compared with that of the cell suspension
treated with 0.2% Triton X-100, was de¢ned as percent hemolysis.
2.4. Molecular mass determination and sequence analysis of the
antimicrobial peptide
The molecular mass of the antimicrobial peptide was determined by
MALDI mass spectroscopy. Approximately 20 nmol of lyophilized
peptide was dissolved in 50% acetonitrile containing 7% (w/v) sina-
pinic acid and mixed with a Pt probe. After removing the solvent in
warm air, the peptide, adsorbed to the Pt probe, was applied to a
vacuum chamber and analyzed. Amino acid sequencing was per-
formed by the automated Edman degradation method on an Applied
Biosystems gas phase sequencer, Model 477A (Foster City, CA).
2.5. Quanti¢cation of peptide
The amount of peptide was determined by amino acid analysis. The
lyophilized peptide was hydrolyzed in 6 N HCl for 24 h at 110³C and
converted to its phenylthiocarbamyl derivative. Samples were then
analyzed using a Pico-tag analysis system on a Beckman 121 MB
amino acid analyzer (Fullerton, CA).
2.6. Peptide synthesis
The isolated antimicrobial peptide was synthesized by the solid-
phase synthesis method on a Milligen 9050 Pepsynthesizer according
to £uoren-9-methyloxycarbony (Fmoc)-polypeptide active ester chem-
istry. The synthesized peptide was puri¢ed by reverse-phase HPLC
and the purity was con¢rmed by amino acid analysis and MALDI
mass spectroscopy.
2.7. Scanning electron microscopy
Scanning electron microscopy (SEM) was conducted as described
previously by Shi et al. [21].
2.8. Circular dichroism
Circular dichroism (CD) spectra were measured in either 50 mM
NAPB, or 50% (v/v) tri£uoroethanol in 50 mM NAPB, on a Jasco
model J-715 spectropolarimeter with a cell path length of 1 mm. Five
scans per sample were performed over the wavelength range 200^
250 nm [22]. The contents of K-helix, L-sheet and unordered structures
were estimated as described by Yang et al. [23].
3. Results
3.1. Puri¢cation of the antimicrobial peptide
Loaches were homogenized in an acidic medium in order to
maximize solubilization of peptides. As a result, the extracts
were mostly composed of low-molecular-mass peptides. The
active eluate, after heparin-a¤nity chromatography, was fur-
ther fractionated by reverse-phase HPLC into one single, ac-
tive peak (Fig. 1A). However, the active peak was found to
contain three peptides on tricine^SDS^PAGE (Fig. 1D, lane
3). Therefore, gel-permeation HPLC was used to isolate the
antimicrobial peptide from the active, single peak of reverse-
phase HPLC (Fig. 1B). The antimicrobial peptide puri¢ed by
gel-permeation HPLC was con¢rmed to be about 95% homo-
geneous by reverse-phase HPLC (Fig. 1C), tricine^SDS^
PAGE (Fig. 1D, lane 4) and MALDI mass spectroscopy
(Fig. 2), and named misgurin (derived from the genus name
of the loach `Misgurnus'). The total amount of puri¢ed mis-
gurin recovered was 0.1 Wg/g loach. The puri¢ed misgurin was
used for further chemical and biological analyses.
3.2. Primary structure determination
The molecular mass of misgurin was determined to be
2502 Da by MALDI mass spectroscopy, along with a small
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Table 1
Antimicrobial activities of misgurin and magainin 2
Microorganism Minimal inhibitory concentrations (Wg/ml)
a
misgurin synthetic misgurin magainin 2
Gram positive
Bacillus subtilis 8 8 50
Staphylococcus aureus 8 8 50
Streptococcus mutans 16 16 100
Streptococcus pneumoniae 8 8 50
Pseudomonas putida 8 8 50
Gram negative
Escherichia coli 8 8 100
Salmonella typhimurium 8 8 25
Serratia sp. 16 16 50
Fungi
Candida albicans 16 16 25
Cryptococcus neoformans 8 8 12
Saccharomyces cerevisiae 4 4 25
a
Minimal inhibitory concentrations were determined by observing the zone of inhibition of growth of microorganisms around 3-mm wells
containing serial dilutions of antimicrobial peptides. See Section 2 for details.
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Fig. 1. Puri¢cation of misgurin. (A) Reverse-phase HPLC chromatogram of the active fraction after heparin chromatography. The active frac-
tion was loaded on a 3.9U300 mm Delta-pak C18 column and elution was achieved with a linear gradient of acetonitrile in aqueous TFA
(80% acetonitrile/0.1% TFA). The elution position of the active peak is indicated by the arrow. (B) Gel-permeation HPLC chromatogram of
the active peak after reverse-phase HPLC. The active peak was loaded on a 8U300 mm Protein KW-802.5 gel-¢ltration HPLC column. The
elution position of misgurin is indicated by the arrow. (C) Reverse-phase HPLC pro¢le of misgurin after gel-permeation HPLC with a slow
gradient. (D) Tricine^SDS^PAGE of loach peptides. Lane 1, loach crude extracts; lane 2, active fraction after heparin chromatography; lane 3,
active peak after reverse-phase HPLC; lane 4, pure misgurin after gel-permeation HPLC. The molecular mass size markers (lane M) have the
following sizes: 17, 14.5, 8, 6, 3.5 and 2 kDa.
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minor peak of molecular mass 2537 Da representing the mis-
gurin containing one Cl
3
ion (Fig. 2). The complete sequence
of misgurin was Arg^Gln^Arg^Val^Glu^Glu^Leu^Ser^Lys^
Phe^Ser^Lys^Lys^Gly^Ala^Ala^Ala^Arg^Arg^Arg^Lys. The
amino acid composition of misgurin, analyzed by the acid
hydrolysis method (data not shown), and its molecular mass
determined by MALDI mass spectroscopy were in good
agreement with those obtained from the amino acid sequence.
These results indicated that additional post-translational mod-
i¢cations were not present in misgurin.
A computer search comparing this amino acid sequence
with all those published in the GenBank
TM
/EMBL Data
Bank ¢le revealed that misgurin was a novel antimicrobial
peptide.
3.3. Antimicrobial activity of the isolated peptides and synthetic
peptide
The antimicrobial activity of misgurin was tested on 11
di¡erent microorganisms, including Gram-negative and
Gram-positive bacteria and fungi. As shown in Table 1, mis-
gurin displayed a strong antimicrobial activity against a broad
spectrum of bacteria, including B. subtilis, Staphylococcus au-
reus, Streptococcus mutans, Streptococcus pneumoniae, Esche-
richia coli, Serratia sp., Pseudomonas putida and Salmonella
typhimurium. Furthermore, Candida albicans, Saccharomyces
cerevisiae and Cryptococcus neoformance were also killed. In
addition, as compared to magainin 2 puri¢ed from Xenopus
laevis, misgurin was approximately 6 times more potent
against a broad range of microorganisms. Synthetic misgurin
was also as active as the natural one. However, no appreciable
hemolytic activity was observed for misgurin (up to 100 Wg/
ml) when tested against sheep red blood cells (Table 2).
3.4. SEM
The e¡ect of misgurin and magainin 2 on the cell mem-
brane of B. subtilis was examined under SEM. Peptides
were added to bacteria and incubated for 1 h under the
same conditions as in the antimicrobial assay. At the MIC,
grooves developed on the surface of B. subtilis, indicating the
disintegration of the cell membrane (Fig. 3C). At the concen-
tration 5 times higher than the MIC, the cells ruptured and
shrank as shown in Fig. 3D. It was evident from the electron
micrographs that the inhibition of bacterial growth was asso-
ciated with the destruction of the bacterial membrane (Fig.
3D).
3.5. Circular dichroism
The secondary structure of synthetic misgurin was esti-
mated using a spectropolarimeter in the absence and presence
of tri£uoroethanol (Fig. 4). The contents of K-helix, L-sheet
and unordered structure was calculated according to Yang et
al. [23]. The CD spectrum of misgurin in 50 mM NAPB was
characteristic of an unordered structure with 0% helical con-
tent. In the presence of 50% tri£uoroethanol, the peptide be-
came structured, exhibiting a high level, i.e. 63%, of K-helical
folding, 4% L-sheet and 33% unordered structure.
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Table 2
Hemolytic activities of misgurin and magainin 2
Concentrations % Hemolysis of sheep red blood cells
(Wg/ml) misgurin magainin 2
5 0.00 0.19
10 0.00 0.19
25 0.23 0.57
50 0.23 0.95
100 0.46 1.14
Fig. 2. Mass spectroscopic analysis of misgurin. Mass for misgurin (MH

=2502) was determined by MALDI mass spectrometry.
C.B. Park et al./FEBS Letters 411 (1997) 173^178176
4. Discussion
The present study describes the puri¢cation and character-
ization of a novel antimicrobial peptide from the loach, which
showed potent antimicrobial activities against a broad range
of microorganisms, but without signi¢cant hemolytic activity.
Antimicrobial peptides have been discovered from various life
forms, from insect to human, and are now recognized as a
type of innate immunity across life forms [14]. However, few
¢sh antimicrobial peptides have been reported. To our knowl-
edge, our peptide represents one of the ¢rst antimicrobial
peptides isolated from ¢sh which dose not possess signi¢cant
hemolytic activity. Misgurin was puri¢ed to homogeneity by a
three-step protocol using heparin-a¤nity chromatography, re-
verse-phase HPLC and gel-permeation HPLC. The homoge-
neity of the ¢nal preparation was assessed by amino acid
analysis (data not shown), automated amino acid sequence
determination, mass spectrometry analysis and solid-phase
synthesis. MALDI mass spectrometry identi¢ed a molecular
ion with a molecular mass of 2502 Da. This value was in good
agreement with the calculated mass obtained from the amino
acid sequence of misgurin, which indicated the absence of any
secondary modi¢cations (carboxamidation, O- and/or N-gly-
cosidation, phosphorylation) of the constitutive amino acid
side chains. De¢nitive con¢rmation of the proposed structure
was achieved through solid-phase synthesis of misgurin. Syn-
thetic misgurin showed chemical and physical properties that
were indistinguishable from those of the natural compound.
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Fig. 3. SEMs of B. subtilis treated with magainin 2 or misgurin. B. subtilis, in mid-logarithmic growth at 10
7
cells/ml, was incubated with the
antimicrobial peptides for 1 h. (A) Medium only; (B) magainin, 50 Wg/ml (MIC); (C) misgurin, 8 Wg/ml (MIC); (D) misgurin, 40 Wg/ml. White
bars represent 0.1 Wm.
Fig. 4. CD spectra of misgurin in 50 mM NAPB in the absence or
the presence of tri£uoroethanol. The concentration of misgurin was
12 WM. Measurements were taken in 50 mM NAPB in the absence
(dashed line) or in the presence (solid line) of 50% tri£uoroethanol.
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Comparison of the misgurin amino acid sequence with those
in the GenBank
TM
/EMBL Data Bank ¢le con¢rmed that mis-
gurin was a novel molecule. The primary amino acid sequence
of misgurin can be ¢tted to an K-helical structure using an
Edmundson wheel projection as shown in Fig. 5. The pre-
dicted amphipathic K-helical structure is strongly supported
by the delineation of a hydrophobic and hydrophilic face on
the Edmundson wheel projection. Further evidence for the
amphipathic K-helical structure was obtained through CD
measurement of misgurin in NAPB bu¡er, or in 50% tri£uo-
roethanol. The CD spectra of misgurin in aqueous bu¡er were
characteristic of a non-structured conformation. In the pres-
ence of a helix promoting solvent, however, misgurin became
structured with a rather high level, i.e. 63%, of K-helix con-
formation. Misgurin did not show any homology with other
known antimicrobial peptides, but structurally it belongs to
one major group of antimicrobial peptides: the amphipathic
K-helical peptides without cysteine (Fig. 5). The members of
this group include cecropins [5], magainins [4], buforins [10]
and dermaseptin [24]. Recent studies with several antimicro-
bial peptides from this family suggested that the peptides kill
microorganisms either by forming pores and increasing the
permeability [25], or by disintegration of cell membrane [26].
Misgurin may kill microorganisms in a way similar to that of
the amphipathic K-helical antimicrobial peptide, because
grooves were evident under SEM on the outer membrane of
B. subtilis treated with misgurin at its MIC (Fig. 3C). The
same result was also observed in bacteria treated with mag-
ainin 2, a well-known pore-forming peptide (Fig. 3B). Misgur-
in is highly basic (net +7) due to the presence of multiple
arginine and lysine residues. This gives it an advantage over
other antimicrobial peptides, including magainin 2 (net +4), in
the initial contact with the target organisms, resulting in an
increased antimicrobial activity. According to the suggested
action mode, misgurin binds preferentially to the negatively
charged phospholipids, and lies on the surface of membrane
such that the positive charges of the basic amino acids interact
with negatively charged phospholipid head groups or water
molecules. It probably then rotates, leading to reorientation of
the hydrophobic residues toward the hydrophobic core of the
membrane. Finally, disintegration of the membrane occurs
when the lipid packing in the bilayer structure is disrupted
[26]. The cDNA cloning of misgurin and its gene expression
mechanism in the loach are now under study.
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Fig. 5. Edmundson wheel representation of misgurin.
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